Zolmitriptan N-Oxide

• CAT Number: R007840
• CAS Number: 251451-30-6
• Molecular Formula: C₁₆H₂₁N₃O₃
• Molecular Weight: 303.36
• Purity: ≥95%
• Synonyms: (4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone
• Storage: Desiccate at +4 ℃
• IUPAC Name: N,N-dimethyl-2-[5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl]ethanamine oxide
• InChI: 1S/C16H21N3O3/c1-19(2,21)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-22-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)
• InChIKey: GZYCQRZFJIZOKU-UHFFFAOYSA-N
• SMILES: C[N+](C)(CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3)[O-]

Zolmitriptan N-Oxide(Cat No.: R007840) is a metabolite of the antimigraine drug zolmitriptan, used in pharmaceutical and biochemical research. It is essential for studying the pharmacokinetics, pharmacodynamics, and metabolic pathways of zolmitriptan. This compound aids in understanding the drug’s mechanism of action, therapeutic efficacy, and safety profile. Researchers rely on Zolmitriptan N-Oxide for precise and reliable results in advanced migraine research and drug development, contributing significantly to innovations in migraine treatment and the development of new therapeutic agents.